HemaComply-Lab Supports LVDS, Pathogen Reduction and 7-Day Platelets To Make Compliance Easier

HemaTerra, a leading software provider to blood and plasma collection centers, and hospitals, provides tools to help organizations manage the process required to extend platelets to seven days and detect bacterial contamination before transfusion. The new guidance and updated requirements on Bacteria Detection testing can be challenging to implement without the right system. HemaComply–Lab makes it easier and can help platelet manufacturing processes comply with the new guidance.

HemaComply–Lab, a complete Quality Management System, makes it easier to track platelet dating extensions, manage tests, and stay within the guidelines and best practices for the detection of bacterial contaminants. HemaComply–Lab successfully executes the configured tests and processes that can significantly impact platelet availability and lower costs. HemaComply–Lab also enables users to build, track and monitor QC Plans in real time, manage pathogen reduction processes, and ensure that sampling plans are statistically significant.

Simon Dawson, Chief Technical Officer of HemaTerra Technologies, said “keeping pace with the industry’s growing need for pathogen reduction, 7-day platelets, and other technologies helps our customers to easily adopt the requirements to ensure compliance.”

About HemaTerra

HemaTerra provides industry-leading software that integrates to provide blood, plasma, and hospital organizations with a broad view of their supply chain for complete operations management. The suite of products assists customers with hospital order entry, donor recruitment, mobile drives, collections staffing, product QC, and equipment maintenance. Integration removes the barriers of information across departments so that customers can seamlessly run their entire operations.